Dr Jennifer Martin Discusses How Insomnia Has Evolved & Affects In Insurance Coverage
In this video, Jennifer Martin, PhD, Assistant Professor, UCLA, David School of Medicine, shares her thoughts on how non-pharmacologic treatments for the management of insomnia has evolved over the past few years and how the increased use of behavioral treatments might affect insurance coverage.
This video was taken on June 3, 2013, at the Sleep 2013 Conference in Baltimore, MD.
California advocates worry that having half its children in Medi-Cal will mean poor access to care. But the real issue may be the growing number of poor children nationwide and the overall effect on Medicaid.
Reports say NIH would receive funds to collect DNA from 1 million volunteers, the National Cancer Institute would get research funds, and FDA would get support to regulate molecular diagnostic tests. The plans need funding from Congress.
The Genetic Information Nondiscrimination Act (GINA) protects most consumers from losing health coverage or their job if they pursue genetic testing. But authors of a new article in The New England Journal of Medicine explore the implications of testing for life, disability and long-term care insurance.